Most Active Healthtech Investors 2026

7 firms ranked by verified Healthtech deal count, led by Andreessen Horowitz, Redpoint, Sequoia Capital — with the companies behind each ranking.

Healthtech accounts for 120 tracked companies with verified cap-table data, 120 of which disclose round sizes totalling $44B. The median disclosed raise is $200M, and the largest is HistoSonics at $2.3B, ahead of GoodRx ($1.6B) and Tempus ($1.4B).

The names that recur most often on these healthtech cap tables are General Catalyst (12 companies), Andreessen Horowitz (6 companies), Sequoia Capital (5 companies), Index Ventures (5 companies), Thrive Capital (5 companies), Transformation Capital (5 companies). By latest disclosed round, the market skews Series C (26), Series D (25), Series B (19), Series E (12).

Best funded Healthtech companies

  1. HistoSonics — $2.3B (latest: IPO)
  2. GoodRx — $1.6B (latest: IPO)
  3. Tempus — $1.4B (latest: IPO)
  4. Oscar Health — $1.4B (latest: IPO)
  5. Oura — $1.2B (latest: Series E)
  6. Owlet Baby Care — $1.1B (latest: IPO)
  7. Lyra Health — $1B (latest: Series G)
  8. Ro — $1B (latest: Series D)
  9. Carbon Health — $983M (latest: Series D)
  10. Waystar — $968M (latest: IPO)
  11. Neko Health — $960M (latest: Series B)
  12. Olive — $902M (latest: Series E)
  13. Cityblock Health — $900M (latest: Series B)
  14. Abridge — $758M (latest: Series D)
  15. Alan — $747M (latest: Series F)

More Healthtech research (2)

Research on comparable markets (14)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library